Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1–6 in Brazil

Efficacy and safety of glecaprevir/pibrentasvir in treatment-naïve adults with chronic hepatitis C virus genotypes 1–6 in Brazil

Introduction and objectives: Glecaprevir/pibrentasvir is a highly effective and well tolerated treatment for hepatitis C infection. Brazilian patients were not included in the original development studies for glecaprevir/pibrentasvir. This study aimed to assess safety and efficacy of glecaprevir/pib...

Full description

Bibliographic Details
Main Authors: Mario Peribañez-Gonzalez, Hugo Cheinquer, Lino Rodrigues, Maria Patelli Lima, Mário Reis Álvares-da-Silva, José Madruga, Edison Roberto Parise, Mário Guimarães Pessoa, Juvencio Furtado, Marcia Villanova, Adalgisa Ferreira, Felipe Mazzoleni, Ecio Nascimento, Giovanni Faria Silva, Linda Fredrick, Preethi Krishnan, Margaret Burroughs, Tania Reuter
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Annals of Hepatology
Subjects:
Antiviral agents
Brazil
Hepatitis C
Liver cirrhosis
Glecaprevir and pibrentasvir
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268120301721

Internet

http://www.sciencedirect.com/science/article/pii/S1665268120301721

Similar Items